Literature DB >> 28295686

Increased insulin-stimulated glucose uptake in both leg and arm muscles after sprint interval and moderate-intensity training in subjects with type 2 diabetes or prediabetes.

T J Sjöros1,2, M A Heiskanen1, K K Motiani1, E Löyttyniemi3, J-J Eskelinen1, K A Virtanen1,4, N J Savisto1, O Solin1,5, J C Hannukainen1, K K Kalliokoski1.   

Abstract

We investigated the effects of sprint interval training (SIT) and moderate-intensity continuous training (MICT) on glucose uptake (GU) during hyperinsulinemic euglycemic clamp and fatty acid uptake (FAU) at fasting state in thigh and arm muscles in subjects with type 2 diabetes (T2D) or prediabetes. Twenty-six patients (age 49, SD 4; 10 women) were randomly assigned into two groups: SIT (n=13) and MICT (n=13). The exercise in the SIT group consisted of 4-6×30 s of all-out cycling with 4- minute recovery and in the MICT group 40- to 60- minute cycling at 60% of VO2peak . Both groups completed six training sessions within two weeks. GU and FAU were measured before and after the intervention with positron emission tomography in thigh (quadriceps femoris, QF; and hamstrings) and upper arm (biceps and triceps brachii) muscles. Whole-body insulin-stimulated GU increased significantly by 25% in both groups, and this was accompanied with significantly increased insulin-stimulated GU in all thigh and upper arm muscles and significantly increased FAU in QF. Within QF, insulin-stimulated GU improved more by SIT than MICT in rectus femoris (P = .01), but not differently between the training modes in the other QF muscles. In individuals with T2D or prediabetes, both SIT and MICT rapidly improve insulin-stimulated GU in whole body and in the thigh and arm muscles as well as FAU in the main working muscle QF. These findings highlight the underused potential of exercise in rapidly restoring the impaired skeletal muscle metabolism in subjects with impaired glucose metabolism.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  exercise; insulin resistance; muscle metabolism

Mesh:

Substances:

Year:  2017        PMID: 28295686     DOI: 10.1111/sms.12875

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  12 in total

1.  Comment on 'Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial'. Reply to Amini P and Moharamzadeh S [letter].

Authors:  Marja A Heiskanen; Kumail K Motiani; Andrea Mari; Jari-Joonas Eskelinen; Kirsi A Virtanen; Eliisa Löyttyniemi; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  Diabetologia       Date:  2018-11-08       Impact factor: 10.122

2.  Short-term interval training alters brain glucose metabolism in subjects with insulin resistance.

Authors:  Sanna M Honkala; Jarkko Johansson; Kumail K Motiani; Jari-Joonas Eskelinen; Kirsi A Virtanen; Eliisa Löyttyniemi; Juhani Knuuti; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-29       Impact factor: 6.200

3.  Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: a randomized trial.

Authors:  Kumail K Motiani; Anna M Savolainen; Jussi Toivanen; Jari-Joonas Eskelinen; Minna Yli-Karjanmaa; Kirsi A Virtanen; Virva Saunavaara; Marja A Heiskanen; Riitta Parkkola; Merja Haaparanta-Solin; Olof Solin; Nina Savisto; Eliisa Löyttyniemi; Juhani Knuuti; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  J Appl Physiol (1985)       Date:  2019-04-18

4.  Sprint interval training decreases left-ventricular glucose uptake compared to moderate-intensity continuous training in subjects with type 2 diabetes or prediabetes.

Authors:  Marja A Heiskanen; Tanja J Sjöros; Ilkka H A Heinonen; Eliisa Löyttyniemi; Mikko Koivumäki; Kumail K Motiani; Jari-Joonas Eskelinen; Kirsi A Virtanen; Juhani Knuuti; Jarna C Hannukainen; Kari K Kalliokoski
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

Review 5.  Exercise as 'precision medicine' for insulin resistance and its progression to type 2 diabetes: a research review.

Authors:  Fred J DiMenna; Avigdor D Arad
Journal:  BMC Sports Sci Med Rehabil       Date:  2018-11-23

6.  Intramyocellular lipid accumulation after sprint interval and moderate-intensity continuous training in healthy and diabetic subjects.

Authors:  Tanja Sjöros; Virva Saunavaara; Eliisa Löyttyniemi; Mikko Koivumäki; Ilkka H A Heinonen; Jari-Joonas Eskelinen; Kirsi A Virtanen; Jarna C Hannukainen; Kari K Kalliokoski
Journal:  Physiol Rep       Date:  2019-02

7.  Exercise Training Modulates Gut Microbiota Profile and Improves Endotoxemia.

Authors:  Kumail K Motiani; M Carmen Collado; Jari-Joonas Eskelinen; Kirsi A Virtanen; Eliisa Löyttyniemi; Seppo Salminen; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  Med Sci Sports Exerc       Date:  2020-01

8.  Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.

Authors:  Marja A Heiskanen; Kumail K Motiani; Andrea Mari; Virva Saunavaara; Jari-Joonas Eskelinen; Kirsi A Virtanen; Mikko Koivumäki; Eliisa Löyttyniemi; Pirjo Nuutila; Kari K Kalliokoski; Jarna C Hannukainen
Journal:  Diabetologia       Date:  2018-05-02       Impact factor: 10.122

9.  Exercise training improves adipose tissue metabolism and vasculature regardless of baseline glucose tolerance and sex.

Authors:  Sanna Maria Honkala; Piryanka Motiani; Riikka Kivelä; Karthik Amudhala Hemanthakumar; Erik Tolvanen; Kumail Kumar Motiani; Jari-Joonas Eskelinen; Kirsi A Virtanen; Jukka Kemppainen; Marja Anneli Heiskanen; Eliisa Löyttyniemi; Pirjo Nuutila; Kari K Kalliokoski; Jarna Christina Hannukainen
Journal:  BMJ Open Diabetes Res Care       Date:  2020-08

10.  High intensity interval training protects the heart during increased metabolic demand in patients with type 2 diabetes: a randomised controlled trial.

Authors:  Jose Suryanegara; Sophie Cassidy; Vladan Ninkovic; Dejana Popovic; Miljan Grbovic; Nduka Okwose; Michael I Trenell; Guy G MacGowan; Djordje G Jakovljevic
Journal:  Acta Diabetol       Date:  2018-11-01       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.